These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20081798)

  • 1. [The new scheme of cavinton application to the treatment of chronic neurosensory loss of hearing].
    Afon'kin VIu; Dobretsov KG; Sipkin AV
    Vestn Otorinolaringol; 2009; (6):69-70. PubMed ID: 20081798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacophysiotherapy in combined treatment of neurosensory hypoacusis in the presence of circulatory disorders in the vertebral arteries].
    Starokha AV; Khandazhapova IuA; Soldatenko MV; Solodilov VIu; Davydov AV
    Vestn Otorinolaringol; 2007; (4):4-6. PubMed ID: 17828103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensorineural hearing loss: New prospects for therapy].
    Kornienko AM; Kornienko RA
    Vestn Otorinolaringol; 2011; (2):46-8. PubMed ID: 21512486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The neurologists's view of the etiology and treatment of sensorineural hearing impairment].
    Dadasheva MN; Agafonov BV; Shevtsova NN
    Vestn Otorinolaringol; 2013; (1):85-7. PubMed ID: 23528474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous laser irradiation of blood for the combined treatment of patients presenting with chronic sensorineural hearing loss].
    Vestn Otorinolaringol; 2011; (2):43-5. PubMed ID: 21512485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant tissue-type plasminogen activator for the treatment of sudden and chronic hearing loss.
    Mora R; Dellepiane M; Mora F; Jankowska B
    Int Tinnitus J; 2005; 11(2):181-4. PubMed ID: 16639920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
    Odinak MM; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894
    [No Abstract]   [Full Text] [Related]  

  • 9. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
    Maliavina US; Ovchinnikov IuM; Fasenko VP; Maliev BM; Kalinina MV; Dadasheva BB
    Vestn Otorinolaringol; 2003; (3):35-40. PubMed ID: 12847806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open trial of methotrexate as treatment for autoimmune hearing loss.
    Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
    Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL.
    Hong SM; Park CH; Lee JH
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):579-83. PubMed ID: 19861194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of pharmacologic therapy combined with hyperbaric oxygen in sensorineural hearing loss following acute acoustic trauma. Preliminary report].
    Winiarski M; Kantor I; Smereka J; Jurkiewicz D
    Pol Merkur Lekarski; 2005 Sep; 19(111):348-50. PubMed ID: 16358866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracochlear disorders of sound conduction in chronic neurosensory hearing loss].
    Ryndina AM; Grachev KV; Kvasova TV; Utianova TA; Tsvyleva ID
    Vestn Otorinolaringol; 1988; (4):11-4. PubMed ID: 3188320
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.
    Choung YH; Park K; Shin YR; Cho MJ
    Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients.
    Zadeh MH; Storper IS; Spitzer JB
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):92-8. PubMed ID: 12574765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.